Kathryn Andrews
Director of Finance/CFO chez GENETIC TECHNOLOGIES LIMITED
Profil
Kathryn J.
E.
Andrews is currently the Chief Financial Officer & Secretary at Genetic Technologies Ltd.
She previously held the position of Chief Financial Officer & Secretary at Percheron Therapeutics Ltd.
from 2002 to 2006 and at Alterity Therapeutics Ltd.
from 2014 to 2024.
Additionally, she has worked as the Chief Financial Officer at Immuron Ltd.
Ms. Andrews completed her undergraduate degree at the University of Melbourne.
Postes actifs de Kathryn Andrews
| Sociétés | Poste | Début |
|---|---|---|
| GENETIC TECHNOLOGIES LIMITED | Director of Finance/CFO | 25/03/2024 |
Anciens postes connus de Kathryn Andrews
| Sociétés | Poste | Fin |
|---|---|---|
| ALTERITY THERAPEUTICS LIMITED | Director of Finance/CFO | 31/01/2024 |
| PERCHERON THERAPEUTICS LIMITED | Director of Finance/CFO | 01/01/2006 |
| IMMURON LIMITED | Director of Finance/CFO | - |
Formation de Kathryn Andrews
| University of Melbourne | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| GENETIC TECHNOLOGIES LIMITED | Health Technology |
| PERCHERON THERAPEUTICS LIMITED | Health Technology |
| ALTERITY THERAPEUTICS LIMITED | Health Technology |
| IMMURON LIMITED | Health Technology |
